ASNR 2022 Annual Meeting
Attending ASNR22? Stop by Booth #109 to learn about our complete solution for early detection, diagnosis, and management of neurological disorders.
The future of MS biomarkers: key takeaways from ACTRIMS 2022
ACTRIMS 2022 highlighted novel scientific discoveries for multiple sclerosis (MS), with a focus on MS biomarkers. Read key takeaways from Peter Ngum, Combinostics Clinical Application Specialist, from better, novel treatments to the potential of enhanced AI-based neuroimaging for improved patient management.
Combinostics Selected to Progress to the Finals of neurotechprize
Combinostics has been selected by the jury to progress to the finals for the neurotechprize run by EIT Health and Biogen. The award recognizes technological innovations for the diagnosis and care of Alzheimer’s patients.
Meet the Team: Peter Ngum, Clinical Application Specialist
In the third edition of our “Meet the Team” blog series, we talk to Peter Ngum, one of Combinostics’ Clinical Application Specialists, about his academic and industry experience, what he loves about his role, and some fascinating conferences he’s attended recently.
![Read more about the article Decreased gray—white matter contrast of [11C]-PiB uptake in cognitively unimpaired subjects with severe obstructive sleep apnea](https://www.combinostics.com/wp-content/uploads/2022/02/Publications_JPAD_500x300.jpg)
Decreased gray—white matter contrast of [11C]-PiB uptake in cognitively unimpaired subjects with severe obstructive sleep apnea
The Journal of Prevention of Alzheimer's Disease S. Ylä-Herttuala, M. Hakulinen, P. Poutiainen, J. Lötjönen,…
Early detection and differentiation of dementias: with AI, vast amounts of data are an asset, not a burden
Although detection of and differentiation among the various types of dementia remain challenging for clinicians, technological advances such as artificial intelligence (AI) and machine learning (ML) can help.
Combinostics Not Impacted by Apache Log4j Vulnerability
We are confident that Combinostics is not affected by the recent vulnerabilities found in Apache Log4j. We will continue to track updates relating to this vulnerability.
Using innovation and AI to redefine radiology: 5 takeaways from RSNA 2021
The theme of RSNA 2021 was “Redefining Radiology,” and, according to our CEO Richard Hausmann, the event delivered. Read Richard's 5 takeaways, from the potential of AI for radiology to the importance of data for patient care.
Combinostics Demonstrates Latest cNeuro® Features and Applications at RSNA 2021
Combinostics will demonstrate the features of cNeuro® 2.0, the latest release to their AI-based suite of products, and applications under development at RSNA 2021.
Arterys Partners with Combinostics to Accelerate Accurate and Consistent Evaluations of Patients with Neurodegenerative Disease and Multiple Sclerosis
Arterys has partnered with Combinostics to offer the most comprehensive neuro AI suite on the market, covering a broad set of applications in neuroradiology .
- Go to the previous page
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- …
- 11
- Go to the next page
